SCHEMBL21698147

SCHEMBL21698147

CP(=O)(O)OCC1OC(n2cnc3c(N)ncnc32)C[C@@H]1OP(C)(=O)O

nearest known ligand 0.71

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
POLB P06746 1/20 0.61
P2RY1 P47900 4/20 0.58
ENPP1 P22413 2/20 0.58
SRC P12931 2/20 0.56
P2RY2 P41231 2/20 0.56
DNPH1 O43598 1/20 0.56
PRKAB2 O43741 1/20 0.56
TRPM2 O94759 1/20 0.56
LDHA P00338 1/20 0.56
ADRB2 P07550 1/20 0.56
FBP1 P09467 1/20 0.56
ADORA1 P30542 1/20 0.56
PRKAG1 P54619 1/20 0.56
PRKAA2 P54646 1/20 0.56
PDE4D Q08499 1/20 0.56
KCNH2 Q12809 1/20 0.56
PRKAA1 Q13131 1/20 0.56
PDE3A Q14432 1/20 0.56
SMN1; SMN2 Q16637 1/20 0.56
TAS1R3 Q7RTX0 1/20 0.56

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13259507 1.00 POLB (0.61) POLBP2RY1ENPP1SRCP2RY2
SCHEMBL16691022 0.96 POLB (0.61) POLBP2RY1ENPP1SRCP2RY2
SCHEMBL17122140 0.93 POLB (0.58) POLBP2RY1ENPP1SRCP2RY2
SCHEMBL18311990 0.93 POLB (0.61) POLBP2RY1ENPP1SRCP2RY2
SCHEMBL16919748 0.93 POLB (0.61) POLBP2RY1ENPP1SRCP2RY2
SCHEMBL16920517 0.93 POLB (0.61) POLBP2RY1ENPP1SRCP2RY2
SCHEMBL20643550 0.92 POLB (0.57) POLBP2RY1ENPP1SRCP2RY2
SCHEMBL23790957 0.92 POLB (0.57) POLBP2RY1ENPP1SRCP2RY2
SCHEMBL16691001 0.92 POLB (0.57) POLBP2RY1ENPP1SRCP2RY2
SCHEMBL26068420 0.91 POLB (0.59) POLBP2RY1ENPP1SRCP2RY2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4223315-A2 METHOD FOR SYNTHESIS OF REACTIVE CONJUGATE CLUSTERS Ionis Pharmaceuticals, Inc. (US) 2023-08-09 EP disclosed
EP-4219718-A2 COMPOSITIONS AND METHODS FOR MODULATING COMPLEMENT FACTOR B EXPRESSION Ionis Pharmaceuticals, Inc. (US) 2023-08-02 EP disclosed
EP-3862362-A2 CONJUGATES OF MODIFIED ANTISENSE OLIGONUCLEOTIDES AND THEIR USE FOR MODULATING PKK EXPRESSION Ionis Pharmaceuticals, Inc. (US) 2021-08-11 EP disclosed
EP-3811977-A1 METHOD FOR SYNTHESIS OF REACTIVE CONJUGATE CLUSTERS Ionis Pharmaceuticals, Inc. (US) 2021-04-28 EP disclosed
EP-3690049-A1 COMPOSITIONS AND METHODS FOR MODULATING APOLIPOPROTEIN C-III EXPRESSION Ionis Pharmaceuticals, Inc. (US) 2020-08-05 EP disclosed
EP-3608406-A1 COMPOSITIONS AND METHODS FOR MODULATING COMPLEMENT FACTOR B EXPRESSION Ionis Pharmaceuticals, Inc. (US) 2020-02-12 EP disclosed